Development of a 3D-bioprinted tumour-on-chip with tunable hydrogel properties for monitoring colorectal cancer cell migration and invasion
Year: 2026
Type: article
Abstract: Understanding the mechanisms governing cancer cell migration is essential for elucidating the early events of colorectal cancer metastasis. Here, we report the development of a light-tunable three-dimensional (3D) bioprinted tumour-on-chip platform for monitoring the migration of colorectal cancer cells under biomimetic microenvironmental conditions. The platform integrates digital light processing (DLP)-based 3D bioprinting with microfluidic technology to recreate structural and mechanical features of the colorectal tumour microenvironment. A hybrid bioink composed of gelatin methacryloyl (GelMA), Matrigel, and type I collagen was formulated to balance DLP printability with biologically relevant extracellular matrix components. Multi-compartment tumour constructs were fabricated with HCT116 colorectal cancer cells spatially confined within a central tumour region, while human umbilical vein endothelial cells (HUVECs) were incorporated into surrounding compartments under co-culture conditions. By modulating the projected light intensity, constructs with tunable properties were generated to investigate the influence of matrix mechanics and transport on cancer cell behaviour. Comparison of Day 1 and Day 4 fluorescence images revealed outward redistribution of the HCT116-positive signal beyond the initially printed tumour core, consistent with colorectal cancer cell migration. The extent of this redistribution was influenced by the light-defined matrix properties and the presence of the neighbouring HUVEC-containing co-culture compartment, highlighting the combined role of physicochemical and cellular cues in regulating tumour cell behaviour. The system also establishes a foundation for future studies of tumour invasion, endothelial barrier interactions, and therapeutic screening under controlled perfusion conditions, supporting the advancement of personalized cancer models and anti-metastatic drug development.
Source: Materials Today Bio
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $3,400
OpenAlex ID: W7207802319
